Enhancing hair regrowth using rapamycin-primed mesenchymal stem cell-derived exosomes

Area of Science:

• Regenerative Medicine
• Dermatology
• Cell Biology

Background:

• Hair loss is a widespread condition with limited effective treatments.
• Mesenchymal stem cells (MSCs) and their exosomes show therapeutic promise for hair regeneration.
• Rapamycin enhances MSC function by promoting growth factor release.

Purpose of the Study:

• To investigate the efficacy of rapamycin-primed MSC-derived exosomes (REXO) for promoting hair regrowth.
• To evaluate the in vitro and in vivo effects of REXO in a murine model.

Main Methods:

• MSCs were primed with rapamycin, and exosomes were extracted.
• In vitro studies assessed REXO effects on dermal fibroblast proliferation and gene expression.
• In vivo studies involved intradermal injection of REXO into depilated mice, monitoring hair regrowth, gene expression, and histology.

Main Results:

• REXO treatment increased dermal fibroblast proliferation and upregulated genes associated with Wnt/β-catenin signaling, autophagy, and growth factors.
• In vivo, REXO therapy significantly enhanced hair follicle development, hair density, and hair activation markers compared to controls.
• Histological examination confirmed improved hair follicle regeneration.

Conclusions:

• Rapamycin priming enhances the therapeutic potential of MSC-derived exosomes for hair regrowth.
• REXO therapy represents a promising and effective approach for treating hair loss.